Position in ELAN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$427,988
+$23,251 QoQ
Shares Held
17,885
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026STOREBRAND ASSET MANAGEMENT AS holds $76,715,400 across 6 Drug Manufacturers - Specialty & Generic names. ELAN ranks #4 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
93,743 | $55,587,724 | |
| 2 | ZTS |
Zoetis Inc.
|
91,260 | $10,787,844 | |
| 3 | VTRS |
Viatris Inc
|
726,652 | $9,817,068 | |
| 4 | ELAN |
Elanco Animal Health Inc
This page
|
17,885 | $427,988 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
581 | $76,540 | |
| 6 | HCM |
HUTCHMED (China) Ltd
|
1,219 | $18,236 |
All Filings in ELAN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $427,988 | 17,885 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $404,737 | 17,885 | Shares | Sole | 2026-05-20 | |
| 2025-09-30 | $564,161 | 28,012 | Shares | Sole | 2026-06-03 | |
| 2025-06-30 | $400,011 | 28,012 | Shares | Sole | 2026-06-03 | |
| 2025-03-31 | $636,636 | 60,632 | Shares | Sole | 2026-06-03 | |
| 2024-12-31 | $879,852 | 72,655 | Shares | Sole | 2026-06-17 | |
| 2024-09-30 | $2,403,989 | 163,648 | Shares | Sole | 2026-06-17 | |
| 2024-06-30 | $2,361,440 | 163,648 | Shares | Sole | 2026-06-17 | |
| 2024-03-31 | $3,702,299 | 227,414 | Shares | Sole | 2026-06-17 | |
| 2023-12-31 | $4,013,717 | 269,377 | Shares | Sole | 2026-06-18 | |
| 2023-09-30 | $3,281,405 | 291,940 | Shares | Sole | 2026-06-18 | |
| 2023-06-30 | $3,565,948 | 354,468 | Shares | Sole | 2026-06-18 | |
| 2023-03-31 | $2,837,737 | 301,887 | Shares | Sole | 2026-06-18 | |
| 2022-12-31 | $1,422,469 | 116,405 | Shares | Sole | 2026-06-18 | |
| 2022-09-30 | $1,598,941 | 128,843 | Shares | Sole | 2026-06-18 | |
| 2022-06-30 | $2,841,442 | 144,750 | Shares | Sole | 2026-06-18 | |
| 2022-03-31 | $4,296,370 | 164,675 | Shares | Sole | 2026-06-18 | |
| 2021-12-31 | $5,771,044 | 203,349 | Shares | Sole | 2026-06-18 | |
| 2021-09-30 | $6,316,197 | 198,062 | Shares | Sole | 2026-06-18 | |
| 2021-06-30 | $6,821,823 | 196,651 | Shares | Sole | 2026-06-18 | |
| 2021-03-31 | $5,988,686 | 203,351 | Shares | Sole | 2026-06-18 | |
| 2020-12-31 | $6,121,057 | 199,578 | Shares | Sole | 2026-06-18 | |
| 2020-09-30 | $5,560,192 | 199,076 | Shares | Sole | 2026-06-18 | |
| 2020-06-30 | $4,253,427 | 198,295 | Shares | Sole | 2026-06-18 | |
| 2020-03-31 | $3,894,919 | 173,958 | Shares | Sole | 2026-06-18 | |
| No filing history on record for this holder in this stock. | ||||||